The metabolic syndrome: an emerging health epidemic in women.
D008076:Cholesterol, HDL / Q000502:physiology; D008078:Cholesterol, LDL / Q000502:physiology; D002839:Chromans / Q000494:pharmacology / Q000627:therapeutic use; D004730:Endothelium, Vascular / Q000503:physiopathology; D005260:Female; D018149:Glucose Intolerance / Q000503:physiopathology; D015438:Health Behavior; D006801:Humans; D006946:Hyperinsulinism / Q000503:physiopathology; D007004:Hypoglycemic Agents / Q000494:pharmacology / Q000627:therapeutic use; D007333:Insulin Resistance / Q000502:physiology; D008019:Life Style; D024821:Metabolic Syndrome / Q000453:epidemiology / Q000503:physiopathology*; D009765:Obesity / Q000503:physiopathology; D000077154:Rosiglitazone; D045162:Thiazolidinediones / Q000494:pharmacology / Q000627:therapeutic use; D000077288:Troglitazone
D008076:Cholesterol, HDL; D008078:Cholesterol, LDL; D002839:Chromans; D007004:Hypoglycemic Agents; D045162:Thiazolidinediones; D000077154:Rosiglitazone; D000077288:Troglitazone